Richard Leduc

Constitutive Activation of the Angiotensin II Type 1 Receptor Alters the Spatial Proximity of Transmembrane 7 to the Ligand-binding Pocket*

Pierre Lavigne, R. Leduc, E. Escher, 2003, Journal of Biological Chemistry.

C-Terminal modifications of apelin-13 significantly change ligand binding, receptor signaling, and hypotensive action.

Olivier Lesur, Philippe Sarret, O. Lesur, 2015, Journal of medicinal chemistry.

Critical Hydrogen Bond Formation for Activation of the Angiotensin II Type 1 Receptor*

Pierre Lavigne, R. Leduc, E. Escher, 2012, The Journal of Biological Chemistry.

Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Pascal Tétreault, Nicolas Beaudet, Philippe Sarret, 2014, The Journal of clinical investigation.

Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2.

Rafael Najmanovich, R. Najmanovich, R. Leduc, 2014, Journal of medicinal chemistry.

Processing of Transforming Growth Factor 1 Precursor by Human Furin Convertase (*)

R. Leduc, C. Dubois, M. Laprise, 1995, The Journal of Biological Chemistry.

Analysis of the Third Transmembrane Domain of the Human Type 1 Angiotensin II Receptor by Cysteine Scanning Mutagenesis*

R. Leduc, E. Escher, G. Guillemette, 2004, Journal of Biological Chemistry.

The signaling signature of the neurotensin type 1 receptor with endogenous ligands

Philippe Sarret, Sandrine Lavenus, R. Leduc, 2017, European journal of pharmacology.

Determining the Environment of the Ligand Binding Pocket of the Human Angiotensin II Type I (hAT1) Receptor Using the Methionine Proximity Assay*

Pierre Lavigne, R. Leduc, E. Escher, 2005, Journal of Biological Chemistry.